Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease

Clinical implications

Pietro Pietrini, Maura L. Furey, Neill Graff-Radford, Ulderico Freo, Gene E Alexander, Cheryl L. Grady, Alessio Dani, Marc J. Mentis, Mark B. Schapiro

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Objective: A subgroup of patients with Alzheimer's disease present with visual disturbances at onset. This study investigated whether specific cortical networks associated with visual processes are preferentially affected in this subgroup and determined the clinical implications of such abnormalities. Method: Regional cerebral glucose metabolic rates were assessed with positron emission tomography and [18F]2-fluoro-2-deoxy-D- glucose, and general intellectual functions, memory, and visual skilled were measured with cognitive tests in patients with probable Alzheimer's disease - 10 with and 22 without prominent visual symptoms - and in 25 healthy comparison subjects. Results: Both patient groups showed reduced glucose metabolism in parietal regions and in middle and superior temporal regions in comparison with the healthy subjects. The Alzheimer's disease patients without visual symptoms also showed reductions in inferior temporal, frontal, and limbic structures, as is typical of Alzheimer's disease. In contrast, the patients with visual symptoms had larger metabolic deficits than the patients without visual symptoms in the parietal and occipital cortices (including the primary visual cortex), with a relative sparing of inferior temporal, frontal, and limbic regions. Consistently, the patients with visual symptoms had significantly greater visuospatial deficits and less severe memory impairments than the patients without visual symptoms. Conclusions: Alzheimer's disease patients with visuospatial deficits who are studied while alive have a distinctive regional distribution of cerebral metabolic impairment that is related to specific cognitive deficits and that distinguishes them from patients with typical Alzheimer's disease. These findings imply that regional variations in brain function can occur in Alzheimer's disease, with differential involvement of cortical systems resulting in distinctive clinical subgroups.

Original languageEnglish (US)
Pages (from-to)1261-1268
Number of pages8
JournalAmerican Journal of Psychiatry
Volume153
Issue number10
StatePublished - Oct 1996
Externally publishedYes

Fingerprint

Alzheimer Disease
Parietal Lobe
Healthy Volunteers
Glucose
Occipital Lobe
Fluorodeoxyglucose F18
Visual Cortex
Temporal Lobe
Positron-Emission Tomography
Brain

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Pietrini, P., Furey, M. L., Graff-Radford, N., Freo, U., Alexander, G. E., Grady, C. L., ... Schapiro, M. B. (1996). Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: Clinical implications. American Journal of Psychiatry, 153(10), 1261-1268.

Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease : Clinical implications. / Pietrini, Pietro; Furey, Maura L.; Graff-Radford, Neill; Freo, Ulderico; Alexander, Gene E; Grady, Cheryl L.; Dani, Alessio; Mentis, Marc J.; Schapiro, Mark B.

In: American Journal of Psychiatry, Vol. 153, No. 10, 10.1996, p. 1261-1268.

Research output: Contribution to journalArticle

Pietrini, P, Furey, ML, Graff-Radford, N, Freo, U, Alexander, GE, Grady, CL, Dani, A, Mentis, MJ & Schapiro, MB 1996, 'Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: Clinical implications', American Journal of Psychiatry, vol. 153, no. 10, pp. 1261-1268.
Pietrini, Pietro ; Furey, Maura L. ; Graff-Radford, Neill ; Freo, Ulderico ; Alexander, Gene E ; Grady, Cheryl L. ; Dani, Alessio ; Mentis, Marc J. ; Schapiro, Mark B. / Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease : Clinical implications. In: American Journal of Psychiatry. 1996 ; Vol. 153, No. 10. pp. 1261-1268.
@article{bc2ce0e154bc4fb08473bf807b05a376,
title = "Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: Clinical implications",
abstract = "Objective: A subgroup of patients with Alzheimer's disease present with visual disturbances at onset. This study investigated whether specific cortical networks associated with visual processes are preferentially affected in this subgroup and determined the clinical implications of such abnormalities. Method: Regional cerebral glucose metabolic rates were assessed with positron emission tomography and [18F]2-fluoro-2-deoxy-D- glucose, and general intellectual functions, memory, and visual skilled were measured with cognitive tests in patients with probable Alzheimer's disease - 10 with and 22 without prominent visual symptoms - and in 25 healthy comparison subjects. Results: Both patient groups showed reduced glucose metabolism in parietal regions and in middle and superior temporal regions in comparison with the healthy subjects. The Alzheimer's disease patients without visual symptoms also showed reductions in inferior temporal, frontal, and limbic structures, as is typical of Alzheimer's disease. In contrast, the patients with visual symptoms had larger metabolic deficits than the patients without visual symptoms in the parietal and occipital cortices (including the primary visual cortex), with a relative sparing of inferior temporal, frontal, and limbic regions. Consistently, the patients with visual symptoms had significantly greater visuospatial deficits and less severe memory impairments than the patients without visual symptoms. Conclusions: Alzheimer's disease patients with visuospatial deficits who are studied while alive have a distinctive regional distribution of cerebral metabolic impairment that is related to specific cognitive deficits and that distinguishes them from patients with typical Alzheimer's disease. These findings imply that regional variations in brain function can occur in Alzheimer's disease, with differential involvement of cortical systems resulting in distinctive clinical subgroups.",
author = "Pietro Pietrini and Furey, {Maura L.} and Neill Graff-Radford and Ulderico Freo and Alexander, {Gene E} and Grady, {Cheryl L.} and Alessio Dani and Mentis, {Marc J.} and Schapiro, {Mark B.}",
year = "1996",
month = "10",
language = "English (US)",
volume = "153",
pages = "1261--1268",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "10",

}

TY - JOUR

T1 - Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease

T2 - Clinical implications

AU - Pietrini, Pietro

AU - Furey, Maura L.

AU - Graff-Radford, Neill

AU - Freo, Ulderico

AU - Alexander, Gene E

AU - Grady, Cheryl L.

AU - Dani, Alessio

AU - Mentis, Marc J.

AU - Schapiro, Mark B.

PY - 1996/10

Y1 - 1996/10

N2 - Objective: A subgroup of patients with Alzheimer's disease present with visual disturbances at onset. This study investigated whether specific cortical networks associated with visual processes are preferentially affected in this subgroup and determined the clinical implications of such abnormalities. Method: Regional cerebral glucose metabolic rates were assessed with positron emission tomography and [18F]2-fluoro-2-deoxy-D- glucose, and general intellectual functions, memory, and visual skilled were measured with cognitive tests in patients with probable Alzheimer's disease - 10 with and 22 without prominent visual symptoms - and in 25 healthy comparison subjects. Results: Both patient groups showed reduced glucose metabolism in parietal regions and in middle and superior temporal regions in comparison with the healthy subjects. The Alzheimer's disease patients without visual symptoms also showed reductions in inferior temporal, frontal, and limbic structures, as is typical of Alzheimer's disease. In contrast, the patients with visual symptoms had larger metabolic deficits than the patients without visual symptoms in the parietal and occipital cortices (including the primary visual cortex), with a relative sparing of inferior temporal, frontal, and limbic regions. Consistently, the patients with visual symptoms had significantly greater visuospatial deficits and less severe memory impairments than the patients without visual symptoms. Conclusions: Alzheimer's disease patients with visuospatial deficits who are studied while alive have a distinctive regional distribution of cerebral metabolic impairment that is related to specific cognitive deficits and that distinguishes them from patients with typical Alzheimer's disease. These findings imply that regional variations in brain function can occur in Alzheimer's disease, with differential involvement of cortical systems resulting in distinctive clinical subgroups.

AB - Objective: A subgroup of patients with Alzheimer's disease present with visual disturbances at onset. This study investigated whether specific cortical networks associated with visual processes are preferentially affected in this subgroup and determined the clinical implications of such abnormalities. Method: Regional cerebral glucose metabolic rates were assessed with positron emission tomography and [18F]2-fluoro-2-deoxy-D- glucose, and general intellectual functions, memory, and visual skilled were measured with cognitive tests in patients with probable Alzheimer's disease - 10 with and 22 without prominent visual symptoms - and in 25 healthy comparison subjects. Results: Both patient groups showed reduced glucose metabolism in parietal regions and in middle and superior temporal regions in comparison with the healthy subjects. The Alzheimer's disease patients without visual symptoms also showed reductions in inferior temporal, frontal, and limbic structures, as is typical of Alzheimer's disease. In contrast, the patients with visual symptoms had larger metabolic deficits than the patients without visual symptoms in the parietal and occipital cortices (including the primary visual cortex), with a relative sparing of inferior temporal, frontal, and limbic regions. Consistently, the patients with visual symptoms had significantly greater visuospatial deficits and less severe memory impairments than the patients without visual symptoms. Conclusions: Alzheimer's disease patients with visuospatial deficits who are studied while alive have a distinctive regional distribution of cerebral metabolic impairment that is related to specific cognitive deficits and that distinguishes them from patients with typical Alzheimer's disease. These findings imply that regional variations in brain function can occur in Alzheimer's disease, with differential involvement of cortical systems resulting in distinctive clinical subgroups.

UR - http://www.scopus.com/inward/record.url?scp=0029786160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029786160&partnerID=8YFLogxK

M3 - Article

VL - 153

SP - 1261

EP - 1268

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 10

ER -